Pertactin-negative variants of Bordetella pertussis in the United States - PubMed (original) (raw)

Pertactin-negative variants of Bordetella pertussis in the United States

Anne Marie Queenan et al. N Engl J Med. 2013.

No abstract available

PubMed Disclaimer

References

    1. Klein NP, Bartlett J, Rowhani-Rahbar A, Firemean B, Baxter R. Waning protection after fifth dose of acellular pertussis vaccine in children. N Eng J Med. 2012;367:1012–1019. -PubMed
    1. Hegerle N, Paris A-S, Brun D, et al. Evolution of French Bordetella pertussis and Bordetella parapertussis isolates: increase of Bordetellae not expressing pertactin. Clin Microbiol Infect. 2012 -PubMed
    1. Barkoff A-M, Mertsola J, Guillot S, Guiso N, Berbers G, He Q. Appearance of Bordetella pertussis strains not expressing the vaccine antigen pertactin in Finland. Clin Vaccine Immunol. 2012;19:1704–1704. -PMC -PubMed
    1. Mooi FR, Hallander H, Wirsing von König CH, Hoet B, Guiso N. Epidemiological typing of Bordetella pertussis isolates: recommendations for a standard methodology. Eur J Clin Microbiol Infect Dis. 2000;19:174–181. -PubMed
    1. Schmidtke AJ, Boney KO, Martin SW, Skoff TH, Tondella ML, Tatti KM. Population diversity among Bordetella pertussis Isolates, United States, 1935–2009. Emerg Infect Dis. 2012;18:1248–1255. -PMC -PubMed

Publication types

MeSH terms

Substances

LinkOut - more resources